Abstract
A comparative study on the metabolic activation and detoxification of the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), by human, rat, and mouse hepatic subcellular fractions was conducted to elucidate the mechanism of the interspecies and organ-specific differences in genotoxicity and carcinogenesis. Incubation of PhIP with human, rat, and mouse hepatic microsomes each generated two metabolites, which were identified as N-hydroxy-PhIP and 4'-hydroxy-PhIP. However, the rates of formation of these metabolites differed significantly between species. Human hepatic microsomes had the highest capacity to convert PhIP to the genotoxic metabolite, N-hydroxy-PhIP, with a mean +/- SD value (9.69 +/- 5.15 nmol/mg protein/30 min, N = 3) that was 1.8-fold and 1.4-fold higher than that of rats (5.25 +/- 1.63, N = 3) and mice (6.89 +/- 0.55, N = 3) p < 0.05), respectively. Rodent microsomes were also able to convert PhIP to its nongenotoxic 4'-hydroxy derivative; however, this detoxification pathway was negligible in human hepatic microsomes. The ratio of N-hydroxylation to 4'-hydroxylation was 97:1, 3.3:1, and 1.7:1 for humans, rats, and mice, respectively. The capacities for the further metabolic activation of N-hydroxy-PhIP by cytosolic O-acetyltransferase, sulfotransferase, L-prolyl-tRNA synthetase, and an ATP-dependent kinase(s) were examined using PhIP-DNA binding as a measure of bioactivation. Acetyl coenzyme A-dependent DNA binding of N-hydroxy-PhIP was detected with both human and rodent hepatic cytosols, and showed a significant interspecies difference.(ABSTRACT TRUNCATED AT 250 WORDS)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|